1231325000: Amfetamine and/or amfetamine derivative dependence in remission (disorder)

• SNOMED CT Concept\Clinical finding (finding)\...
• \Mental state, behavior and/or psychosocial function finding (finding)\Behavior finding\Health-related behavior finding\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\...
• \Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Stimulant dependence\Psychostimulant dependence\...
• \Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Substance dependence in remission\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Stimulant dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Stimulant dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Psychostimulant dependence\...
• \Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Disorder caused by psychoactive substance\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Disorder caused by psychoactive substance\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Disorder caused by stimulant (disorder)\Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Stimulant dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Disorder caused by stimulant (disorder)\Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Stimulant dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Disorder in remission\Substance dependence in remission\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Stimulant dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterized by the pattern and consequences of stimulant use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Stimulant dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Substance dependence in remission\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Stimulant dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Stimulant dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months.\Psychoactive substance dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Psychostimulant dependence\Psychostimulant dependence in remission (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)
• \Disease\Mental disorder\A range of disorders stemming from the single or repeated use of predominantly psychoactive substances, including certain medications. Initially, these substances provide pleasurable effects, encouraging further use. Over time, however, this can lead to dependence and severe mental and physical health issues. These disorders also cover harmful non-medical use of non-psychoactive substances. They result in significant impairment, exhibiting cognitive, behavioural, and physiological symptoms, and persist despite adverse consequences, underscoring their complex and damaging impact.\Disorder characterised by the pattern and consequences of psychoactive substance use leading to clinically significant impairment or distress both to physical or mental health of the user or others around the user.\Psychoactive substance dependence\Psychostimulant dependence\Amfetamine and/or amfetamine derivative dependence (disorder)\Amfetamine and/or amfetamine derivative dependence in remission (disorder)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5072308011	Amfetamine and/or amfetamine derivative dependence in remission (disorder)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5072309015	Amphetamine and/or amphetamine derivative dependence in remission	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5072341014	Amfetamine and/or amfetamine derivative dependence in remission	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1836271000195110	dipendenza da amfetamina e/o derivati dell'amfetamina in remissione	it	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
6499111000241116	dépendance à une amphétamine et/ou à un dérivé amphétaminique en rémission	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
6499121000241111	dépendance à une amphétamine et/ou à l'un de ses dérivés en rémission	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

This concept is not in any reference sets

Back to Start